Medical/Pharmaceuticals
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group
* GC Cell and PT Bifarma Adiluhung announced a strategic partnership to
facilitate the entry of 'Immuncell-LC', the only approved autologous T-cell
therapy for HCC into the Indonesian market. YONGIN, South Korea, June 19, 2024
/PRNewswire/ --GC Cell
2024-06-20 08:44
3274
SINBON and MAKALOT partner to drive cross-industry textile wearable adoption
SAN FRANCISCO, June 19, 2024 /PRNewswire/ -- Digital technology is playing a transformative role in our everyday life, shaping not only how we interact with the world around us but also ourselves. The impact of this trend is most prevalent when examining the wellness landscape, where consumers co...
2024-06-20 00:00
2924
CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A
ATLANTA, June 19, 2024 /PRNewswire/ -- The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease (CMT)*, has formed a strategic partnership with ReviR Therapeutics to advance small molecule therapeutics that modulate the expressio...
2024-06-19 21:00
2564
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma
* Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor approved for the treatment of r/r PTCL based on results from the multinational pivotal JACKPOT8B study. * Golidocitinib monotherapy demonstrated superior and durable clinical benefits and a favorable safety profile in r/...
2024-06-19 19:30
2784
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, in a Phase I/II Clinical Trial Treating Advanced Solid Tumor Patients with KRAS G12D Mutation
SHANGHAI, June 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announcedChina's National Medical Products Administration (NMPA) has approved the clinical trial application for GFH375 (VS-7375) in...
2024-06-19 19:00
2547
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health
BEIJING, June 19, 2024 /PRNewswire/ -- Recently, Professor Jianping Weng of the University of Science and Technology ofChina (USTC) and President of Anhui Medical University and his team of researchers from USTC, Southern Medical University and Peking University published the results of their lat...
2024-06-19 18:10
1918
Smartee Presents Two Decades of Progress at the 99th EOS Congress in Athens
ATHENS, Greece, June 19, 2024 /PRNewswire/ -- Smartee Denti-Technology, a pioneer in clear aligner industry with 20 years of independent research & development and over 850 patents applied, shared its two decades of achievement and full series of products at the 99th Congress of the European Orth...
2024-06-19 16:44
2111
VUNO PRESENTS CUTTING-EDGE AI BRAIN TECHNOLOGY AT AAIC - ANALYZING MRI SCANS IN <1 MINUTE TO SUPPORT DIAGNOSIS OF ALZHEIMER'S DISEASE
Potential partners are invited to explore collaboration opportunities with VUNO
Med®-DeepBrain®, a highly accurate AI solution for research and clinical
settings.
MARLBOROUGH, Mass., June 17, 2024 /PRNewswire/ -- VUNO
2024-06-19 14:14
3718
Tang Prize in Biopharmaceutical Science Honoring Three Scientists
TAIPEI, June 19, 2024 /PRNewswire/ -- In a continuing series of laureate announcements, the Tang Prize Foundationtoday (June 19th) announced the 2024 Tang Prize in Biopharmaceutical Science recipients. The prestigious award has been jointly awarded toJoel F. Habener, Svetlana Mojsov, and Jens Juu...
2024-06-19 12:15
2205
YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China
Strategic Partnership to Advance Gene Editing Technologies in Biomedical Applications SHANGHAI, June 18, 2024 /PRNewswire/ -- YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery forin vivo gene editing therapies, has partnered with KACTUS, a leading developer se...
2024-06-19 09:00
2196
Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally
COLOGNE, Germany, June 18, 2024 /PRNewswire/ -- Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally. Singleron will facilitate access to its single cell analysis platform via the HCA network, by provi...
2024-06-18 21:00
2491
Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
CHENGDU, China, June 18, 2024 /PRNewswire/ -- Qilian International Holding
Group Limited (NASDAQ:QLI
2024-06-18 20:30
4877
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
MAASTRICHT, Netherlands, June 18, 2024 /PRNewswire/ -- Pie Medical Imaging, a global leader in cardiac imaging, announced thecompletion of enrollment in FASTIII, a multi-center randomized clinical trial, which investigates the use of angiography-based vessel fractional flow reserve (CAAS vFFR) in...
2024-06-18 18:00
2648
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals
BRISBANE, Calif. and SHANGHAI, June 17, 2024 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncology indications, and Asieris Pharmaceuticals, a global biopharmaceutical leader in ...
2024-06-17 22:00
2660
CardioFlow's VitaFlow Liberty™ Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap
SHANGHAI, June 17, 2024 /PRNewswire/ -- MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlowLibertyTM Transcatheter Aortic Valve and Retrievabl...
2024-06-17 21:32
2394
Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute
* Gain attention as an alternative technology to the malaria HRP-2/3 gene deletion problem inAfrica * Prepare a bridgehead to enter the U.S. market by securing a credible reference YONGIN, South Korea, June 17, 2024 /PRNewswire/ -- On-Device AI healthcare company, Noul, announced that it will...
2024-06-17 21:00
2888
Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading
HONG KONG, June 17, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, announced the publication of its audited financial results for the year endedDecember...
2024-06-17 20:30
3926
Leads Biolabs Unveils Preclinical Data on LBL-047, a Novel, First-In-Class Long-Acting TACI/Anti-BDCA2 Bispecific Antibody Fusion Protein in an Oral Presentation at EULAR 2024 Congress
NANJING, China, June 17, 2024 /PRNewswire/ -- At the recent European League Against Rheumatism (EULAR) Congress inVienna, Austria, Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) delivered an oral presentation on its highly innovative therapeutic candidate LBL-047. LBL-047 is a first-in-class, l...
2024-06-17 18:00
1921
IASO Bio Presented New Data of FUCASO® (Equecabtagene Autoleucel) for the Treatment of High-risk Newly Diagnosed Multiple Myeloma in Oral Presentation at EHA 2024
SHANGHAI and NANJING, China and SAN JOSE, Calif., June 15, 2024 /PRNewswire/ -- IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented clinical data on the use of Equec...
2024-06-15 22:30
4324
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024
SHANGHAI, June 15, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the initial results from the ongoing first-in-human study of CT0...
2024-06-15 20:50
4152
Week's Top Stories
Most Reposted
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 318 media titles]
2026-01-29 15:06
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00
Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00
True 1000Hz Powerhouse: PHILIPS EVNIA Unleashes the World's First 1000Hz Dual-Mode Gaming Monitor 27M2N5500XD
[Picked up by 282 media titles]
2026-01-29 18:03
Multi-Award Winning Phuket Marriott Resort & Spa, Merlin Beach: Voted Top 3 Best Family Resort
[Picked up by 282 media titles]
2026-01-30 08:00
Most Read
Inside the Computing Power Behind Spatial Filmmaking: Hugh Hou Goes Hands-On at GIGABYTE Suite During CES 2026
2026-01-24 05:00
8326
Lianhe Sowell International Group Ltd Announces Strategic Plan to Establish Specialized Industry Robotics Headquarters in the UAE
2026-01-26 21:30
7529
